Scientific Sessions 2015 delivers top-notch programming

Tracks_LadySpeaker3_MattHerpThe American Heart Association delivered exciting improvements to Scientific Sessions 2015 in Orlando, Florida. It gave attendees bigger science, bigger technology and bigger networking.

The newly structured programming brought more focused areas of interest geared to cover the scope of attendee interest. Whether attendees’ focus was basic, clinical, population or translational, Scientific Sessions lived up to its status as the premier cardiovascular research and instructional meeting in the world.

This year, sessions were organized in 30 areas of interest within tracks structured to help participants navigate the conference. All of the educational tracks, which replaced the cores, fell within five programming areas:

  1. Basic Science delivered state-of-the-art insights into the underlying mechanisms of cardiovascular development and diseases.
  2. Clinical Science focused on the latest clinical and scientific applications in the diagnosis, medical management, prevention and treatment of cardiovascular diseases.
  3. Population Science raised awareness about the most effective population-based approaches to prevent cardiovascular diseases and improve cardiovascular health across populations.
  4. Special Focus delved into various topics within cardiovascular disease that are of continuing concern to clinicians, including the use of innovative tools and technologies.
  5. Frontiers in Science featured speakers interested in pre-discovery and pre-publication who shared concepts and engaged attendees in a rapid-fire format to encourage discussion.

In an effort to bring new programming and address gaps in education, three new daylong learning programs were added:

  • Workplace Health examined the role of employers in the prevention and management of cardiovascular diseases and brought leading researchers in workplace health promotion and health education.

    The day featured leading cardiovascular health scientists, workplace health researchers, behavioral economists, employers and representatives from the Center for Disease Control and Prevention and the National Institutes of Health. Topics included the rationale for cardiovascular disease prevention in the workplace, the utility of using Life’s Simple 7 as an evidence-based metric to assess cardiovascular health, the challenges of implementing interventions within companies, the optimal design of financial incentives, the role of technology and wearables and research designs for workplace health programs.

  • Health Tech explored the role of technology in the treatment and prevention of cardiovascular disease and examined ways to drive innovation and collaboration in the marketplace with a goal of improving outcomes. See article. Speakers from across academia, government and the tech world provided insights on new opportunities and solutions.
  • Clinical Trialists focused on the needs of the clinical trial community with programming that addressed trial methods, conundrums around design, hot issues and contemporary concerns related to conducting clinical trials.